Your browser doesn't support javascript.
loading
Videoconference-delivered group Cognitive Behavioral Stress Management for ME/CFS patients who present with severe PEM: A randomized controlled trial.
May, Marcella; Milrad, Sara F; Perdomo, Dolores M; Czaja, Sara J; Jutagir, Devika R; Hall, Daniel L; Klimas, Nancy; Antoni, Michael H.
Afiliação
  • May M; University of Miami.
  • Milrad SF; University of Maryland/Sheppard Pratt.
  • Perdomo DM; University of Miami.
  • Czaja SJ; Weill Cornell Medical College.
  • Jutagir DR; Memorial Sloan Kettering Cancer Center.
  • Hall DL; Massachusetts General Hospital, Harvard Medical School.
  • Klimas N; Nova Southeastern University, Miami VA Medical Center Geriatric Research Education and Clinical Center.
  • Antoni MH; University of Miami; Sylvester Comprehensive Cancer Center.
Fatigue ; 12(2): 101-122, 2024.
Article em En | MEDLINE | ID: mdl-38736736
ABSTRACT

Background:

In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), post-exertional malaise (PEM) is associated with greater distress and symptoms. Cognitive Behavioral Stress Management (CBSM) has demonstrated beneficial effects for ME/CFS and may mitigate stress-related triggers of PEM. We tested a virtual CBSM intervention to increase access, and we report on its effects on stress and symptoms in ME/CFS patients with severe PEM.

Methods:

Data were from a randomized controlled trial (NCT01650636) comparing 10-week videoconference-delivered group CBSM (V-CBSM, n=75) to a 10-week Health Information active control (V-HI, n=75) in Fukuda criteria ME/CFS patients (71 classified as highPEM, 79 lowPEM). Linear regression explored PEM-by-Treatment interactions on overall symptom frequency and intensity, perceived stress, and fatigue-specific interference and intensity, at 5-month follow-up. Logistic regression tested V-CBSM effects on 5-month PEM status. Analyses controlled for age, gender, race/ethnicity, mode of symptom onset, and time since diagnosis.

Results:

The sample was middle-aged (47.96±10.89 years), mostly women (87%) and non-Hispanic White (65%), with no group differences on these variables or baseline PEM. For highPEM patients, V-CBSM (versus V-HI) demonstrated medium to large effects on follow-up symptom frequency, symptom intensity, fatigue interference, and fatigue intensity (p's < .05) and trending to significant reductions in perceived stress (p =.07). Differences were not evident for lowPEM patients. Treatment predicted follow-up PEM status at a trend (p = .058), with patients receiving V-CBSM demonstrating half the risk of highPEM classification versus V-HI.

Conclusions:

V-CBSM demonstrates benefits for ME/CFS patients presenting with severe PEM and may reduce the expression of PEM over time.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Fatigue Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Fatigue Ano de publicação: 2024 Tipo de documento: Article